These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24613069)

  • 1. Selective inhibition of histone deacetylase 6 alters the composition of circulating blood cells in a lethal septic model.
    Zhao T; Li Y; Liu B; Halaweish I; Mazitschek R; Alam HB
    J Surg Res; 2014 Aug; 190(2):647-54. PubMed ID: 24613069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of histone deacetylase 6 restores innate immune cells in the bone marrow in a lethal septic model.
    Zhao T; Li Y; Liu B; Pan B; Cheng X; Georgoff P; Alam HB
    J Trauma Acute Care Surg; 2016 Jan; 80(1):34-40; discussion 40-1. PubMed ID: 26491797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective histone deacetylase-6 inhibition attenuates stress responses and prevents immune organ atrophy in a lethal septic model.
    Zhao T; Li Y; Bronson RT; Liu B; Velmahos GC; Alam HB
    Surgery; 2014 Aug; 156(2):235-42. PubMed ID: 24947640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
    Li Y; Zhao T; Liu B; Halaweish I; Mazitschek R; Duan X; Alam HB
    J Trauma Acute Care Surg; 2015 Feb; 78(2):378-85. PubMed ID: 25757125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Effect of Tubastatin A in CLP-Induced Lethal Sepsis.
    Deng Q; Zhao T; Pan B; Dennahy IS; Duan X; Williams AM; Liu B; Lin N; Bhatti UF; Chen E; Alam HB; Li Y
    Inflammation; 2018 Dec; 41(6):2101-2109. PubMed ID: 30047002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective histone deacetylase 6 inhibition prolongs survival in a lethal two-hit model.
    Cheng X; Liu Z; Liu B; Zhao T; Li Y; Alam HB
    J Surg Res; 2015 Jul; 197(1):39-44. PubMed ID: 25837686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase inhibitor treatment attenuates coagulation imbalance in a lethal murine model of sepsis.
    Zhao T; Li Y; Liu B; Wu E; Sillesen M; Velmahos GC; Halaweish I; Alam HB
    Surgery; 2014 Aug; 156(2):214-20. PubMed ID: 24957668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase III as a potential therapeutic target for the treatment of lethal sepsis.
    Zhao T; Li Y; Liu B; Bronson RT; Halaweish I; Alam HB
    J Trauma Acute Care Surg; 2014 Dec; 77(6):913-9; discussion 919. PubMed ID: 25051385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects.
    Vishwakarma S; Iyer LR; Muley M; Singh PK; Shastry A; Saxena A; Kulathingal J; Vijaykanth G; Raghul J; Rajesh N; Rathinasamy S; Kachhadia V; Kilambi N; Rajgopal S; Balasubramanian G; Narayanan S
    Int Immunopharmacol; 2013 May; 16(1):72-8. PubMed ID: 23541634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citrullinated histone H3: a novel target for the treatment of sepsis.
    Li Y; Liu Z; Liu B; Zhao T; Chong W; Wang Y; Alam HB
    Surgery; 2014 Aug; 156(2):229-34. PubMed ID: 24957671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis.
    Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y
    J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
    Zhang L; Liu C; Wu J; Tao JJ; Sui XL; Yao ZG; Xu YF; Huang L; Zhu H; Sheng SL; Qin C
    J Alzheimers Dis; 2014; 41(4):1193-1205. PubMed ID: 24844691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model.
    Lee J; Hong EC; Jeong H; Hwang JW; Kim H; Bae EK; Ahn JK; Choi YL; Han J; Cha HS; Koh EM
    Int J Rheum Dis; 2015 Jun; 18(5):514-23. PubMed ID: 25530272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of histone deacetylase 6 restores intestinal tight junction in hemorrhagic shock.
    Chang Z; Li Y; He W; Liu B; Duan X; Halaweish I; Bambakidis T; Pan B; Liang Y; Nikolian VC; Georgoff P; Alam HB
    J Trauma Acute Care Surg; 2016 Sep; 81(3):512-9. PubMed ID: 27257709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel pharmacologic treatment attenuates septic shock and improves long-term survival.
    Zhao T; Li Y; Liu B; Liu Z; Chong W; Duan X; Deperalta DK; Velmahos GC; Alam HB
    Surgery; 2013 Aug; 154(2):206-13. PubMed ID: 23889949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PARP inhibitor olaparib exerts beneficial effects in mice subjected to cecal ligature and puncture and in cells subjected to oxidative stress without impairing DNA integrity: A potential opportunity for repurposing a clinically used oncological drug for the experimental therapy of sepsis.
    Ahmad A; Vieira JC; de Mello AH; de Lima TM; Ariga SK; Barbeiro DF; Barbeiro HV; Szczesny B; Törö G; Druzhyna N; Randi EB; Marcatti M; Toliver-Kinsky T; Kiss A; Liaudet L; Salomao R; Soriano FG; Szabo C
    Pharmacol Res; 2019 Jul; 145():104263. PubMed ID: 31071432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy.
    Shen Z; Ji K; Cai Z; Huang C; He X; Xu H; Chen G
    Aging (Albany NY); 2021 Mar; 13(7):9820-9837. PubMed ID: 33744850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Inhibition of SIRT2 Improves Outcomes in a Lethal Septic Model.
    Zhao T; Alam HB; Liu B; Bronson RT; Nikolian VC; Wu E; Chong W; Li Y
    Curr Mol Med; 2015; 15(7):634-41. PubMed ID: 26299770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.